14 结果
FIELD
This disclosure relates to compositions for white to beige adipogenesis and methods of using the same, which may be used to treat or prevent obesity.
INTRODUCTION
Obesity and its associated disorders are common and very serious public health problems in the United States and throughout the
FIELD OF INVENTION
The present invention relates to a compound for inducing browning of white adipose tissue in vitro and in vivo, the preparation method thereof, as well as a composition comprising the same. Further, the present invention relates to the use of the compound and the method to treat
FIELD OF INVENTION
This invention relates to the field of treating obesity, associated metabolic and physical aberrations such as altered plasma lipid profile and elevated blood pressure.
BACKGROUND
Obesity is rapidly becoming a major health problem in modern society. It is increasing in prevalence
This application is a national phase application under 35 U.S.C. .sctn. 371 of International Application No. PCT/EP2015/053165, filed Feb. 13, 2015, which claims priority to European Application No. 14155088.9, filed Feb. 13, 2014, the entire contents of each of which are incorporated herein by
BACKGROUND OF THE INVENTION
Obesity is a significant health problem. Obesity has reached epidemic proportions globally, and the World Health Organization estimates that there are more than 1 billion overweight adults (BMI of 25.0-29.9), of which at least 300 million are obese (BMI of 30 or above)
BACKGROUND
1. Field of the Invention
The present invention relates to a composition for inducing brown adipocytes and inducing differentiation into beige adipocytes from white adipocytes, the composition including butein, a butein derivative or a pharmaceutically available salt thereof as an active
BACKGROUND
During the past 20 years, there has been a dramatic increase in obesity in the United States and these rates remain high. In 2010, no state had a prevalence of obesity less than 20%. Not only does obesity threaten a significant portion of the United States population, but this health
BACKGROUND OF THE INVENTION
The regulation of body weight, and particularly body fat, in animals is a complex process having enormous implications for the health and well being of humans and other animals. Excess body weight and/or an excess of body fat relative to lean body mass has been associated
BACKGROUND OF THE INVENTION
The regulation of body weight, and particularly body fat, in animals is a complex process having enormous implications for the health and well being of humans and other animals. Excess body weight and/or an excess of body fat relative to lean body mass has been associated
BACKGROUND ART
This invention relates to human pre-adipose cell lines capable to differentiate into adipose cells. In particular, the present invention pertains to pre-adipose cell lines derived from white adipose tissue and their use in developing drugs, food ingredients and supplements against
This application is a national stage filing under 35 U.S.C. 371 of International Application No. PCT/GB01/04074, filed Sep. 12, 2001, which claims priority from United Kingdom Application No. 0022670.4, filed Sep. 15, 2000, the specifications of each of which are incorporated by reference herein.
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to and the benefit of Korean Patent Application No. 10-2014-0078275, filed on Jun. 25, 2014, and 10-2015-0071581, filed on May 22, 2015, the disclosure of which is incorporated herein by reference in its entirety.
SEQUENCE
FIELD OF THE INVENTION
The present invention relates to methods for prevention and/or treatment of metabolic disorders, post-menopausal obesity and conditions associated with high fat diet consumption including, obesity, body weight gain, fat mass formation, bone mineral content reduction, white
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the field of medical treatments for diseases and disorders. More specifically, the present invention relates to biologically active compounds that treat and prevent insulin resistance, impaired glucose tolerance,